Limes Schlosskliniken AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A0JDBC7
EUR
326.00
-14 (-4.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With ROE of 24.92%, it has a Very Expensive valuation with a 5.03 Price to Book Value

  • Over the past year, while the stock has generated a return of -1.10%, its profits have risen by 29.4% ; the PEG ratio of the company is 0.7
2

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 98 Million ()

stock-summary
P/E

20.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.05

stock-summary
Return on Equity

24.92%

stock-summary
Price to Book

4.44

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
18.98%
0%
18.98%
6 Months
-7.39%
0%
-7.39%
1 Year
-6.86%
0%
-6.86%
2 Years
-2.4%
0%
-2.4%
3 Years
22.56%
0%
22.56%
4 Years
101.23%
0%
101.23%
5 Years
256.28%
0%
256.28%

Limes Schlosskliniken AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
35.82%
EBIT Growth (5y)
53.99%
EBIT to Interest (avg)
3.88
Debt to EBITDA (avg)
0.34
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
1.57
Tax Ratio
21.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
34.93%
ROE (avg)
30.48%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
5.03
EV to EBIT
16.07
EV to EBITDA
11.48
EV to Capital Employed
4.83
EV to Sales
2.68
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
30.05%
ROE (Latest)
24.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Limes Schlosskliniken AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 29.86% vs 23.08% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -38.78% vs 19.51% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.40",
          "val2": "28.80",
          "chgp": "29.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.70",
          "val2": "8.70",
          "chgp": "-45.98%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.40",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.00",
          "val2": "4.90",
          "chgp": "-38.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "125.70%",
          "val2": "208.20%",
          "chgp": "-8.25%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
37.40
28.80
29.86%
Operating Profit (PBDIT) excl Other Income
4.70
8.70
-45.98%
Interest
0.00
0.40
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.00
4.90
-38.78%
Operating Profit Margin (Excl OI)
125.70%
208.20%
-8.25%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 29.86% vs 23.08% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -38.78% vs 19.51% in Dec 2022

stock-summaryCompany CV
About Limes Schlosskliniken AG stock-summary
stock-summary
Limes Schlosskliniken AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available